Akademska digitalna zbirka SLovenije - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources SI consortium. For full access, REGISTER.

1 2 3 4
hits: 36
1.
  • Efficacy of combined hypo-f... Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
    Roger, Anissa; Finet, Adeline; Boru, Blandine ... Oncoimmunology, 07/2018, Volume: 7, Issue: 7
    Journal Article
    Peer reviewed
    Open access

    Information on the role of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma patients is limited. We report on a prospective cohort of advanced melanoma patients treated simultaneously ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
2.
  • Efficacy of Large Use of Co... Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients
    Saiag, Philippe; Molinier, Rafaele; Roger, Anissa ... Cancers, 08/2022, Volume: 14, Issue: 17
    Journal Article
    Peer reviewed
    Open access

    To assess the role of radiotherapy in anti-PD-1-treated melanoma patients, we studied retrospectively a cohort of 206 consecutive anti-PD-1 monotherapy-treated advanced melanoma patients (59% M1c/d, ...
Full text
Available for: IZUM, KILJ, NUK, PILJ, PNG, SAZU, UL, UM, UPUK
3.
  • Combined Nivolumab and Ipil... Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
    Reichert, Constance; Baldini, Capucine; Mezghani, Sarah ... Cancers, 08/2023, Volume: 15, Issue: 17
    Journal Article
    Peer reviewed
    Open access

    Data regarding elderly melanoma patients treated with anti-PD-1 or anti-CTLA-4 antibodies are in favor of tolerability outcomes that are similar to those of younger counterparts. However, there are ...
Full text
Available for: IZUM, KILJ, NUK, PILJ, PNG, SAZU, UL, UM, UPUK
4.
Full text
Available for: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
5.
  • Impact of prior treatment w... Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
    Bouchereau, Sarah; Chaplain, Louise; Fort, Magali ... British journal of cancer, 09/2021, Volume: 125, Issue: 7
    Journal Article
    Peer reviewed
    Open access

    Despite its low efficacy, chemotherapy with dacarbazine remains an option in metastatic melanoma patients after failure of immune checkpoint inhibitors (ICI) ± targeted therapy. Some observations ...
Full text
Available for: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
6.
  • The contribution of high-re... The contribution of high-resolution ultrasonography in preoperatively detecting sentinel-node metastases in melanoma patients
    Sibon, Claire; Chagnon, Sophie; Tchakérian, Arnold ... Melanoma research 17, Issue: 4
    Journal Article
    Peer reviewed

    To evaluate the ability of high-resolution ultrasonography (hrUS) to detect sentinel-node (SN) melanoma metastases preoperatively before sentinel-node biopsy (SNB), to define hrUS resolution, and to ...
Full text
Available for: CMK
7.
  • Pembrolizumab and concurren... Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma
    Lavaud, Justine; Blom, Astrid; Longvert, Christine ... EJD. European journal of dermatology, 2019-Dec-01, Volume: 29, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    Background Cutaneous squamous cell carcinoma (cSCC) is the second most frequent non-melanoma skin cancer. Treatment options for inoperable advanced cSCC cases are limited. The efficacy of ...
Full text
Available for: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NUK, OBVAL, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
8.
Full text
Available for: OILJ
9.
  • Incidence and Clinical Impa... Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey
    Lesage, Candice; Longvert, Christine; Prey, Sorilla ... Journal of immunotherapy (1997), 06/2019, Volume: 42, Issue: 5
    Journal Article
    Peer reviewed

    Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and warrant anti-tumor necrosis factor α (TNFα) ...
Full text
Available for: CMK, UL
10.
  • Efficacy of late concurrent... Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti‐PD‐1 monotherapy
    Funck‐Brentano, Elisa; Baghad, Bouchra; Fort, Magali ... International journal of cancer, 15 September 2020, Volume: 147, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    Advanced melanoma patients who failed anti‐PD‐1 therapy have limited options. We analyzed a cohort of 133 advanced melanoma patients receiving anti‐PD‐1 monotherapy in a referral center between April ...
Full text
Available for: BFBNIB, FZAB, GIS, IJS, KILJ, NLZOH, NUK, OILJ, SAZU, SBCE, SBMB, UL, UM, UPUK

PDF
1 2 3 4
hits: 36

Load filters